Biotechnology Assets (Spain) Probability of Future Stock Price Finishing Under 0.33
| BST Stock | 0.34 0.01 3.03% |
Biotechnology |
Biotechnology Assets Target Price Odds to finish below 0.33
The tendency of Biotechnology Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.33 or more in 90 days |
| 0.34 | 90 days | 0.33 | more than 93.0 |
Based on a normal probability distribution, the odds of Biotechnology Assets to drop to 0.33 or more in 90 days from now is more than 93.0 (This Biotechnology Assets SA probability density function shows the probability of Biotechnology Stock to fall within a particular range of prices over 90 days) . Probability of Biotechnology Assets price to stay between 0.33 and its current price of 0.34 at the end of the 90-day period is nearly 4.45 .
Assuming the 90 days trading horizon Biotechnology Assets SA has a beta of -0.24 suggesting as returns on the benchmark increase, returns on holding Biotechnology Assets are expected to decrease at a much lower rate. During a bear market, however, Biotechnology Assets SA is likely to outperform the market. Additionally Biotechnology Assets SA has an alpha of 0.288, implying that it can generate a 0.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Biotechnology Assets Price Density |
| Price |
Predictive Modules for Biotechnology Assets
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotechnology Assets. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biotechnology Assets Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biotechnology Assets is not an exception. The market had few large corrections towards the Biotechnology Assets' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biotechnology Assets SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biotechnology Assets within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.29 | |
β | Beta against Dow Jones | -0.24 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | 0.03 |
Biotechnology Assets Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotechnology Assets for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotechnology Assets can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biotechnology Assets had very high historical volatility over the last 90 days | |
| Biotechnology Assets has some characteristics of a very speculative penny stock | |
| Biotechnology Assets has high likelihood to experience some financial distress in the next 2 years | |
| About 51.0% of the company shares are held by company insiders |
Biotechnology Assets Technical Analysis
Biotechnology Assets' future price can be derived by breaking down and analyzing its technical indicators over time. Biotechnology Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biotechnology Assets SA. In general, you should focus on analyzing Biotechnology Stock price patterns and their correlations with different microeconomic environments and drivers.
Biotechnology Assets Predictive Forecast Models
Biotechnology Assets' time-series forecasting models is one of many Biotechnology Assets' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biotechnology Assets' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biotechnology Assets
Checking the ongoing alerts about Biotechnology Assets for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biotechnology Assets help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biotechnology Assets had very high historical volatility over the last 90 days | |
| Biotechnology Assets has some characteristics of a very speculative penny stock | |
| Biotechnology Assets has high likelihood to experience some financial distress in the next 2 years | |
| About 51.0% of the company shares are held by company insiders |
Other Information on Investing in Biotechnology Stock
Biotechnology Assets financial ratios help investors to determine whether Biotechnology Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Assets security.